Figure 2.The relationship between sarcopenia and OS in TAE or TACE treated HCC patients. (A) The overall analysis; (B) Subgroup analysis including multivariate analysis and univariate analysis.
Figure 2 — The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients | Aging
